This study investigated the effect of stimulating 5-HT(1A) receptors in the dorsal raphe on the impairment of learning caused by 4 μg/μL scopolamine injected in the CA1 region of the dorsal hippocampus in rats performing a two-platform spatial discrimination task. At 1 (but not 0.2) μg/0.5 μL administered in the dorsal raphe on each acquisition training day 5 min before bilateral intrahippocampal injection of 4 μg/μL scopolamine, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), a 5-HT(1A) receptor agonist, had no effect on choice accuracy and latency or errors of omission but completely antagonized the impairment of choice accuracy by intrahippocampal scopolamine. Administered into the dorsal raphe at 0.2 and 1 μg/0.5 μL, WAY 100635, a 5-HT(1A) receptor antagonist, had no effect on rats' performance or on the impairment caused by intrahippocampal scopolamine but dose-dependently antagonized the effect of 1 μg/0.5 μL 8-OH-DPAT on the scopolamine-induced deficit. The results show that stimulation of presynaptic 5-HT(1A) receptors in the dorsal raphe reverses the deficit caused by intrahippocampal scopolamine, probably by facilitating the transfer of facilitatory information from the entorhinal cortex to the hippocampus. Together with a previous study showing that blockade of postsynaptic hippocampal 5-HT(1A) receptors antagonized the effect of intrahippocampal scopolamine in the two-platform spatial discrimination task, the results suggest that drugs with presynaptic stimulatory and postsynaptic blocking actions on 5-HT(1A) receptors, such as partial agonists at these receptors, may be useful in the symptomatic treatment of human memory disturbances associated with loss of cholinergic innervation to the hippocampus.
- Dorsal raphe
- Entorhinal cortex
- Presynaptic 5-HT(1A) receptors
- Spatial learning
ASJC Scopus subject areas